CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder.

Faghihi F, Amani J, Gholami M, Salahshourifar I.

Open source

DOI
10.5812/ijpr-172311
Published
2026-01-01
Container
Iran J Pharm Res
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5812/ijpr-172311,
  title = {CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A\>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder.},
  author = {Faghihi F and  Amani J and  Gholami M and  Salahshourifar I.},
  year = {2026},
  journal = {Iran J Pharm Res},
  doi = {10.5812/ijpr-172311},
  url = {https://doi.org/10.5812/ijpr-172311}
}

RIS

TY  - JOUR
TI  - CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder.
AU  - Faghihi F
AU  -  Amani J
AU  -  Gholami M
AU  -  Salahshourifar I.
PY  - 2026
JO  - Iran J Pharm Res
DO  - 10.5812/ijpr-172311
UR  - https://doi.org/10.5812/ijpr-172311
ER  - 

APA

F, F., J, A., M, G., & I., S. (2026). CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder.. Iran J Pharm Res. https://doi.org/10.5812/ijpr-172311

Source records